Skip to main content
. 2026 Feb 14;27(4):1848. doi: 10.3390/ijms27041848
3′UTR 3′ untranslated region
95%CI 95% confidence interval
ADAM A disintegrin and metalloprotease
ADC Antibody–drug conjugate
aHR Adjusted hazard ratio
ASC Adipose-derived stem cell
ATM Ataxia-telangiectasia mutated
BC Breast cancer
BCSC Breast cancer stem-like cells
BiTE Bispecific T-cell engager
CAR Chimeric antigen receptor
CBS Cystathionine β-synthase
CIK Cytokine-induced killer
CSE Cystathionine γ-lyase
ctDNA Circulating tumor DNA
CTLA4 Cytotoxic T-lymphocyte-associated protein 4
DLTs Dose-limiting toxicities
ECOG PS European Eastern Cooperative Oncology Group performance status
EGFR Epidermal growth factor receptor
EHMT2 Euchromatic histone-lysine N-methyltransferase 2
EphA5 Ephrin type-A receptor 5
ER Estrogen receptor
GSK-3β Glycogen synthase kinase-3 beta
H2BK H2B.K variant histone
H2S Hydrogen sulfide
HER2 Human epidermal growth factor receptor 2
HR Hazard ratio
HSF1 Heat shock factor 1
IGFBP Insulin-like growth factor binding protein
IHC Immunohistochemistry
IL Interleukin
INFγ Interferon gamma
lncRNA Long non-coding RNA
MCT4 Monocarboxylate transporter-4
Met Methionine
MICA Major histocompatibility complex class I-related protein A
MICB Major histocompatibility complex class I-related protein B
miR Micro RNA
MMP Metalloprotease
mOS Median overall survival
mPFS Median progression-free survival
NK Natural killer
NKG2D Natural Killer group 2 member D receptor
NKG2DL NKG2D ligand
nTPM Normalized transcripts per million
ORR Overall response rate
OS Overall survival
PAM50 Predictor analysis of microarray 50
PCLP1 Podocalyxin-like protein 1
PFS Progression-free survival
PD-L1 Protein death ligand 1
PI3K Phosphoinositide 3-kinase
PR Progesterone receptor
RFS Relapse-free survival
RNA-seq RNA sequencing
SCC Senescent cancer cells
sMICA Soluble MICA
sNKG2DL Soluble NKG2D ligand
STAT3 Signal transducer and activator of transcription 3
TCGA The Cancer Genome Atlas
TFGβ Transforming growth factor beta
TNFα Tumor necrosis factor alpha
TNBC Triple-negative breast cancer
TPM Transcripts per million
TRUCK T cells redirected for antigen-unrestricted cytokine-initiated killing
ULBP1 UL16 binding protein 1
ULBP2 UL16 binding protein 2
ULBP3 UL16 binding protein 3
ULBP4 UL16 binding protein 4. Also: RAET1E (Retinoic Acid Early Transcript 1E)
ULBP5 UL16 binding protein 5. Also: RAET1G (Retinoic Acid Early Transcript 1G)
ULBP6 UL16 binding protein 6. Also: RAET1L (Retinoic Acid Early Transcript 1L)
Val Valine
XOR Xanthine oxidoreductase